Roche Secured Option on Antisoma Pipeline
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 31 (Table of Contents)
Published: 2 Dec-2002
DOI: 10.3833/pdr.v2002.i31.964 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Swiss giant Roche secured exclusive worldwide rights to Antisoma’s pipeline of oncology products including Pemtumomab for treating ovarian and gastric cancer, Therex, TheraFab and DMXAA...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS